# Boehringer Ingelheim (France)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/boehringer-ingelheim-france/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 11 |
| Citations | 207,219 |
| City | Paris |
| Country | FR |
| Description | Boehringer Ingelheim (France) is a research organisation in Paris, FR. OpenAlex records 1,808 works and 207,219 citations for it. 611 researchers list it as their most recent affiliation. |
| Homepage | https://www.boehringer-ingelheim.fr/ |
| OpenAlex ID | https://openalex.org/I4210139229 |
| Researchers | 611 |
| ROR ID | https://ror.org/03gdpyq31 |
| Type | company |
| Works | 1,808 |

## University papers

- [Impact of inappropriate antibiotic therapy on mortality in patients with ventilator-associated pneumonia and blood stream infection: A meta-analysis](https://scholariq.org/papers/impact-of-inappropriate-antibiotic-therapy-on-mortality-in-patients-with/)
- [Burden of hospitalization for heart failure in the United States: a systematic literature review](https://scholariq.org/papers/burden-of-hospitalization-for-heart-failure-in-the-united-states-a-systematic/)
- [Cost-Effectiveness of Empagliflozin in Patients With Diabetic Kidney Disease in the United States: Findings Based on the EMPA-REG OUTCOME Trial](https://scholariq.org/papers/cost-effectiveness-of-empagliflozin-in-patients-with-diabetic-kidney-disease-in/)
- [Differences in All-Cause Health Care Utilization and Costs in a Type 2 Diabetes Mellitus Population with and Without a History of Cardiovascular Disease](https://scholariq.org/papers/differences-in-all-cause-health-care-utilization-and-costs-in-a-type-2-diabetes/)
- [Length of Stay and Hospital Costs Associated with a Pharmacodynamic‐Based Clinical Pathway for Empiric Antibiotic Choice for Ventilator‐Associated Pneumonia](https://scholariq.org/papers/length-of-stay-and-hospital-costs-associated-with-a-pharmacodynamic-based/)
- [Student Measurement of Blood Pressure Using a Simulator Arm Compared with a Live Subject's Arm](https://scholariq.org/papers/student-measurement-of-blood-pressure-using-a-simulator-arm-compared-with-a-live/)
- [The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker](https://scholariq.org/papers/the-development-of-new-onset-type-2-diabetes-associated-with-choosing-a-calcium/)
- [Assessing risk of future cardiovascular events, healthcare resource utilization and costs in patients with type 2 diabetes, prior cardiovascular disease and both](https://scholariq.org/papers/assessing-risk-of-future-cardiovascular-events-healthcare-resource-utilization/)
- [Pharmacokinetics, antifungal activity and clinical efficacy of anidulafungin in the treatment of fungal infections](https://scholariq.org/papers/pharmacokinetics-antifungal-activity-and-clinical-efficacy-of-anidulafungin-in/)
- [Cardiovascular event incidence and cost in type 2 diabetes mellitus: a Medicare claims-based actuarial analysis](https://scholariq.org/papers/cardiovascular-event-incidence-and-cost-in-type-2-diabetes-mellitus-a-medicare/)
- [Impact of Caring for Individuals With Heart Failure in the United States](https://scholariq.org/papers/impact-of-caring-for-individuals-with-heart-failure-in-the-united-states/)

## University researchers

- [Effie Kuti](https://scholariq.org/researchers/effie-kuti/)

## University top topics

Showing 8 of 25.

- [Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis](https://scholariq.org/topics/interstitial-lung-diseases-and-idiopathic-pulmonary-fibrosis/)
- [Chronic Obstructive Pulmonary Disease (COPD) Research](https://scholariq.org/topics/chronic-obstructive-pulmonary-disease-copd-research/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [HIV/AIDS drug development and treatment](https://scholariq.org/topics/hiv-aids-drug-development-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.